Young, K., Kelley, C., Balu, S., Weinhold, A., Parish, A., Niedzwiecki, D., … Dinani, A. (2025). S2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care. In American Journal of Gastroenterology (Vol. 120, pp. S515–S515). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/01.ajg.0001137036.82941.12

Young, Karen, Carly Kelley, Suresh Balu, Andy Weinhold, Alice Parish, Donna Niedzwiecki, Heather E. Parnell, and Amreen Dinani. “S2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care.” In American Journal of Gastroenterology, 120:S515–S515. Ovid Technologies (Wolters Kluwer Health), 2025. https://doi.org/10.14309/01.ajg.0001137036.82941.12.

Young K, Kelley C, Balu S, Weinhold A, Parish A, Niedzwiecki D, et al. S2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2025. p. S515–S515.

Young, Karen, et al. “S2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care.” American Journal of Gastroenterology, vol. 120, no. 10S2, Ovid Technologies (Wolters Kluwer Health), 2025, pp. S515–S515. Crossref, doi:10.14309/01.ajg.0001137036.82941.12.

Young K, Kelley C, Balu S, Weinhold A, Parish A, Niedzwiecki D, Parnell HE, Dinani A. S2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2025. p. S515–S515.